194 related articles for article (PubMed ID: 17707828)
1. The normal counterpart to the chronic lymphocytic leukemia B cell.
Caligaris-Cappio F; Ghia P
Best Pract Res Clin Haematol; 2007 Sep; 20(3):385-97. PubMed ID: 17707828
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.
Amato D; Oscier DG; Davis Z; Mould S; Zheng J; Kolomietz E; Wang C
Am J Clin Pathol; 2007 Aug; 128(2):333-8. PubMed ID: 17638670
[TBL] [Abstract][Full Text] [Related]
4. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
6. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
7. Prognostic markers in chronic lymphocytic leukaemia.
Hamblin TJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
[TBL] [Abstract][Full Text] [Related]
8. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
9. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia.
Musolino C; Allegra A; Alonci A; Saija A; Russo S; Cannavò A; Cristani M; Centorrino R; Saitta S; Alibrandi A; Gangemi S
Clin Biochem; 2011 Dec; 44(17-18):1487-90. PubMed ID: 21945028
[TBL] [Abstract][Full Text] [Related]
10. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
[TBL] [Abstract][Full Text] [Related]
11. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
Siddon AJ; Rinder HM;
Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
[TBL] [Abstract][Full Text] [Related]
12. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Rawstron AC; Bennett F; Hillmen P
Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
[TBL] [Abstract][Full Text] [Related]
13. B lymphocytes in humans express ZAP-70 when activated in vivo.
Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
[TBL] [Abstract][Full Text] [Related]
14. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
16. The origin of B-cell chronic lymphocytic leukemia.
Ghia P; Caligaris-Cappio F
Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061
[TBL] [Abstract][Full Text] [Related]
17. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
[TBL] [Abstract][Full Text] [Related]
18. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
19. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
Darwiche W; Gubler B; Marolleau JP; Ghamlouch H
Front Immunol; 2018; 9():683. PubMed ID: 29670635
[TBL] [Abstract][Full Text] [Related]
20. The CD5+ B-cell.
Dono M; Cerruti G; Zupo S
Int J Biochem Cell Biol; 2004 Nov; 36(11):2105-11. PubMed ID: 15313456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]